1448423681
BioBoss

Advertise on podcast: BioBoss

Rating
★★★★★
5
from
7 reviews
This podcast has
100 episodes
Language
English
Publisher
John Simboli
Explicit
No
Date created
2019/01/03
Latest episode
2026/09/22
Average duration
35 min.
Release period
35 days

Description

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.

Unlock BioBoss podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from BioBoss podcast


Ryan Beal: Co-Founder and CEO of Dyve Biosciences
2026/09/22
Ryan Beal, CEO of Dyve Biosciences, shares his insights about leadership in biopharma and how Dyve is working to deliver targeted pH modulation to treat a range of immunologic and oncologic diseases.
Haseeb Ahmad - CEO of Purespring Therapeutics
2026/08/25
Haseeb Ahmad, CEO of Purespring Therapeutics, shares his insights about leadership in biopharma and how Purespring is working to help patients with kidney diseases to live fuller, healthier lives.
Lance Baldo: CEO of Beacon Therapeutics
2026/07/29
Lance Baldo, CEO of Beacon Therapeutics, shares his insights about leadership in biopharma and how Beacon is working to save and restore sight for people living with rare and prevalent ocular diseases.
Shaun Bagai: CEO of RenovoRX
2026/06/25
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Hyung Heon Kim: CEO of MetaVia
2026/05/06
Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.
David Southwell: CEO of Volastra Therapeutics
2026/02/28
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerability of cancers.
Stacy Lindborg: CEO of Imunon
2026/01/26
Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.
Welcome to Season 8 of BioBoss
2025/12/20
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026
Michael Cloonan: CEO of Sionna Therapeutics
2025/11/22
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
Erik van den Berg: CEO of Memo Therapeutics
2025/10/27
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Bruce Leuchter: CEO of Neurvati Neurosciences
2025/09/29
Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of people living with neurological and psychiatric disorders.
Todd Harris: CEO of Tyra Biosciences
2025/08/30
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
Eduardo Bravo: CEO of Citryll
2025/07/26
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
Abbas Kazimi: CEO of Nimbus Therapeutics
2025/06/28
Abbas Kazimi, CEO of Nimbus Therapeutics, shares his insights about leadership in biopharma and how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives.
Derek Adams: CEO of Stellular Bio
2025/05/24
Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.

Podcast reviews

Read BioBoss podcast reviews


5 out of 5
7 reviews

Podcast sponsorship advertising

Start advertising on BioBoss relevant audience podcasts


What do you want to promote?